• FirefoxInstall the new Firefox »
  •  Dow Down 0.11% Nasdaq Down 0.06%

    More On ABBV.PA

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    AbbVie Inc. (ABBV.PA)

    -Paris
    54.00 Down 0.59(1.08%) Feb 24
    Add to Portfolio
    Prev Close:54.00
    Open:54.00
    Bid:54.01
    Ask:54.57
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:54.00 - 54.00
    52wk Range:36.63 - 61.80
    Volume:68
    Avg Vol (3m):N/A
    Market Cap:86.04B
    P/E (ttm):49.09
    EPS (ttm):1.10
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in EUR.

    Headlines

    • No Headlines available for ABBV.PA at this time.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):4.31
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company’s products include HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; VIEKIRA PAK, an all-o... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback